EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease

Gene L Bowman, Jeffrey A Kaye, Joseph F Quinn

Current Gerontology and Geriatrics Research · 2012 · 2012 · 1-5

DOI: 10.1155/2012/184042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Gerontology and Geriatrics Research, 2012. Verfasst von Gene L Bowman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Oregon Health and Science University, 3181 Southwest Samuel Jackson Park Road, Portland, OR 97239, USA. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIA NIH HHS, NCCIH NIH HHS, National Center for Complementary and Alternative Medicine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Blood-brain barrier (BBB) dysfunction may have a significant role in the pathogenesis of Alzheimer's disease (AD). Modifiable factors associated with BBB function may have therapeutic implication. This study tested the hypothesis that dyslipidemia is associated with BBB impairment in mild-to-moderate AD.

Methods

Thirty-six subjects with AD were followed for 1 year. Fasting CSF and plasma were collected with clinical assessments at baseline and 12 months. BBB impairment was defined as CSF albumin index ≥9. Independent t -tests and linear regression assessed the relationship between plasma lipoproteins and BBB integrity.

Results

Dyslipidemia was prevalent in 47% of the population, and in 75% of those with BBB impairment. Subjects with BBB impairment had significantly higher mean plasma triglyceride and lower HDL cholesterol (TG, P = 0.007 ; HDL, P = 0.043 ). Plasma triglycerides explained 22% of the variance in BBB integrity and remained significant after controlling for age, gender, ApoE-4 genotype, blood pressure, and statin use.

Conclusion

Dyslipidemia is more prevalent in AD subjects with BBB impairment. Plasma triglyceride and HDL cholesterol may have a role in maintaining BBB integrity in mild-to-moderate Alzheimer's disease.

Autor:innen und Institutionen

  • Department of Neurology, Oregon Health and Science University, 3181 Southwest Samuel Jackson Park Road, Portland, OR 97239, USA.

Förderung

  • NIA NIH HHS
  • NCCIH NIH HHS
  • National Center for Complementary and Alternative Medicine
  • National Institute on Aging

Zitieren

APA

Bowman, G. L., Kaye, J. A., & Quinn, J. F. (2012). Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease. Current Gerontology and Geriatrics Research, 2012, 1-5. https://doi.org/10.1155/2012/184042

Vancouver

Bowman GL, Kaye JA, Quinn JF. Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease. Current Gerontology and Geriatrics Research. 2012;2012:1-5. doi:10.1155/2012/184042

BibTeX
@article{Bowman2012,
  author = {Bowman, Gene L and Kaye, Jeffrey A and Quinn, Joseph F},
  title = {Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease},
  journal = {Current Gerontology and Geriatrics Research},
  year = {2012},
  volume = {2012},
  pages = {1--5},
  doi = {10.1155/2012/184042}
}
Kostenlos starten →